Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pacanowski

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|April 20, 2019
An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical TrialsOluseyi Adeniyi, Anuradha Ramamoorthy, Robert Schuck, et al.
Clinical Pharmacology and Therapeutics|December 5, 2020
Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney FunctionNita A Limdi, Timothy Mark Beasley, Jielin Sun, et al.
Journal of Clinical Pharmacology|April 5, 2016
How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?Chakradhar V Lagishetty, Jiexin Deng, Lawrence J Lesko, et al.
Journal of Clinical Pharmacology|April 16, 2025
Clinical Pharmacology Guidances Advancing Drug Development and Regulatory Assessment: Role and OpportunitiesAnuradha Ramamoorthy, Daphne Guinn, Elimika Pfuma Fletcher, et al.
The Journal of Clinical Psychiatry|October 13, 2012
CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendationsHobart L Rogers, Atul Bhattaram, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|March 17, 2024
Assessment of Dosing Strategies for Pediatric Drug ProductsZachary L Taylor, Francis G Green, Nayeem Hossain, et al.
Plos Computational Biology|December 12, 2018
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic developmentJennifer L Wilson, Rebecca Racz, Tianyun Liu, et al.
Circulation|October 14, 2015
Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research PerspectiveAlison Blaus, Rajanikanth Madabushi, Michael Pacanowski, et al.
Clinical Pharmacology and Therapeutics|September 16, 2018
Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017Anuradha Ramamoorthy, Todd C Knepper, Christine Merenda, et al.
Clinical and Translational Science|September 22, 2023
Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolismYuen Yi Hon, Jie Wang, Henrietta Abodakpi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|April 20, 2019
An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical TrialsOluseyi Adeniyi, Anuradha Ramamoorthy, Robert Schuck, et al.
Clinical Pharmacology and Therapeutics|December 5, 2020
Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney FunctionNita A Limdi, Timothy Mark Beasley, Jielin Sun, et al.
Journal of Clinical Pharmacology|April 5, 2016
How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?Chakradhar V Lagishetty, Jiexin Deng, Lawrence J Lesko, et al.
Journal of Clinical Pharmacology|April 16, 2025
Clinical Pharmacology Guidances Advancing Drug Development and Regulatory Assessment: Role and OpportunitiesAnuradha Ramamoorthy, Daphne Guinn, Elimika Pfuma Fletcher, et al.
The Journal of Clinical Psychiatry|October 13, 2012
CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendationsHobart L Rogers, Atul Bhattaram, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|March 17, 2024
Assessment of Dosing Strategies for Pediatric Drug ProductsZachary L Taylor, Francis G Green, Nayeem Hossain, et al.
Plos Computational Biology|December 12, 2018
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic developmentJennifer L Wilson, Rebecca Racz, Tianyun Liu, et al.
Circulation|October 14, 2015
Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research PerspectiveAlison Blaus, Rajanikanth Madabushi, Michael Pacanowski, et al.
Clinical Pharmacology and Therapeutics|September 16, 2018
Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017Anuradha Ramamoorthy, Todd C Knepper, Christine Merenda, et al.
Clinical and Translational Science|September 22, 2023
Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolismYuen Yi Hon, Jie Wang, Henrietta Abodakpi, et al.
Pageof 5